主頁 > 生活百科 > 癌症治療｜白血球不達標延誤治療社區藥劑師解構營養補充同走抗癌路

癌症治療｜白血球不達標延誤治療社區藥劑師解構營養補充同走抗癌路

編輯: Fion

日期: 2023-06-30

抗癌是一場漫長戰爭，但並不是孤軍作戰！不少癌症病人都需要長期服藥來控制病情，不過癌症治療的同時，藥物也會為病人的身體帶來副作用。龍豐集團註冊藥劑師Billy Chung望與患者同行，他不時到醫院向病人講解用藥迷思，並提醒患者除了定時服藥和接受癌症治療外，也應注意營養補充，透過攝取含免疫營養的癌症專用營養補充品，以提升免疫力，有助順利完成整個癌症療程。

參考資料：

^速癒素™減糖配方營養品每100毫升含4.3克糖比原配方速癒素™營養品每100毫升含7.5克糖少43%糖

#每食用份量

1. How Is Chemotherapy Used to Treat Cancer?, American Cancer Society, Available at: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-is-chemotherapy-used-to-treat-cancer.html, Accessed 3 May 2023

2. How Chemotherapy Affects the Immune System, Breast Cancer Org, Available at: https://www.breastcancer.org/managing-life/immune-system/cancer-treatments/chemotherapy

3. Why People with Cancer Are More Likely to Get Infections, American Cancer Society, Available at: https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/low-blood-counts/infections/why-people-with-cancer-are-at-risk.html, Accessed 31 May 2023

4. Machon C, et al. Support Care Cancer 2012;20:3129–3135.

5. McClave SA, et al. J Parenter and Enter Nutri 2016;40:159-211

6. Weimann A, et al. Clin Nutr 2017;36:623–650

7. Muscaritoli M, Arends J, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition 40 (2021) 2898-2913

8. 17. Diabetes UK. Diabetes and Cancer. https://wwwdiabetesorguk/diabetes-the-basics/related-conditions/diabetes-and-cancer. Accessed 31 May 2023

9. Ariaans, et al. Jalving Cancer-drug induced insulin resistance: innocent bystander or unusual suspect. Cancer Treat Rey 2015, 41: 376-384.

10. Honors M, et al. The role of insulin resistance in the development of muscle wasting during cancer cachexia. J Cachexia Sarcopenia Muscle. 2012;3:5-11.

11. Hershey, D.S, Importance of glycemic control in cancer patients with diabetes: treatment through end of life. Asia Pac. J. Oncol. Nurs. 2017; 4,313-318

12.Hershey DS et al. Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis. Asia Pac J Oncol Nurs 2017;4:224-32. 10.4103

13. Maruyama T et al. Nutrition 2011;27:146-152

特殊醫用食品。遵照醫生或醫護人員指示下飲用。

*此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

以上內容及產品建議為受訪者個人意見僅供參考，建議患者先諮詢醫生或專業醫護人員，再按個人身體情况及病情等，選擇最適合的營養補充方案。